Resistance to Erythropoiesis Stimulating Agents in Patients Treated with Online Hemodiafiltration and Ultrapure Low-Flux Hemodialysis: Results from a Randomized Controlled Trial (CONTRAST)

Resistance to erythropoiesis stimulating agents (ESA) is common in patients undergoing chronic hemodialysis (HD) treatment. ESA responsiveness might be improved by enhanced clearance of uremic toxins of middle molecular weight, as can be obtained by hemodiafiltration (HDF). In this analysis of the r...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Weerd, Neelke C., Den Hoedt, Claire H., Blankestijn, Peter J., Bots, Michiel L., van den Dorpel, Marinus A., Lévesque, Renée, Mazairac, Albert H. A., Nubé, Menso J., Penne, E. Lars, ter Wee, Pieter M., Grooteman, Muriel P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990567/
https://www.ncbi.nlm.nih.gov/pubmed/24743493
http://dx.doi.org/10.1371/journal.pone.0094434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990567/
https://www.ncbi.nlm.nih.gov/pubmed/24743493
http://dx.doi.org/10.1371/journal.pone.0094434

Ejemplares similares